The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative ...

Building in Houston expands Eli Lilly’s United States production at a time when its competitor, Novo Nordisk, maker of ...

The Danish pharmaceutical giant, which is looking to revive growth, used to be Europe's most valuable company listed on ...

As evidence grows supporting the potential health benefits of obesity drugs like Novo Nordisk’s Wegovy and Eli Lilly & Co.’s Zepbound, so too — frustratingly — do the barriers to accessing them.

One of them is already a leader in the market for weight management drugs, and the other could join this field.

Finding undervalued stocks isn't easy these days. The average stock price for companies in the benchmark S&P 500 index has ...

Novo Nordisk, the maker of blockbuster weight-loss drug Wegovy, said on Wednesday it will cut 9,000 jobs in a bid to reignite ...

The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.

Novo, which has 78,400 positions globally, said about 5,000 of the job cuts will be in its native Denmark. Read more at ...

Working-age Americans who get health insurance through their job will see largest health insurance rate hikes since 2010.

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it ...

There are fears Denmark is facing a so-called “Nokia risk”. Read more at straitstimes.com. Read more at straitstimes.com.